Clinical Trial VICCTHO1078


Nashville Early Diagnosis Lung Cancer Project

Principal Investigator(s)

Pierre Massion


  • Protocol No. VICCTHO1078
  • Open Date: 04/12/2011
  • Staging: NA
  • Age Group: Adults
  • Scope: Local
  • Objective: To analyze the associate between suspected lung cancer risk factors and outcomes such as pre-malignant lesions and diagnosis of lung cancer. To identify and validate biomarkers that are associated with lung cancer risk factors and pre-malignant lesions. To assess the association between patient characteristics and test results to the genetic and histological characteristics of lung preinvasive lesions and cancers. To describe this high-risk cohort and to identify the patients eligible for future clinical trials (e.g. chemoprevention).
  • Disease Sites: Miscellaneous; Lung
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Veterans Administration; Vanderbilt University
  • National Clinical Trial ID: NCT01475500
  • Secondary Protocol No: VICC THO 1078



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.